India’s economic growth is at a crossroads, and the private sector is being counted on to drive the next phase of investment.

Jefferies maintained a Buy rating on Cognizant Technology Solutions (NASDAQ:CTSH) stock and increased the price target to ...

Wilson will be based in Melbourne and joins Jarden after its equity capital markets team ended 2024 on the No.5 spot on the ...

Brent Thill, Jefferies tech analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on Palantir, why he has an ...

Jefferies reaffirms 'Buy' on ONGC, citing growth from BP partnership and policy changes. Target price: Rs 375. Read more now.

Jefferies maintains a Buy rating on JB Pharma citing strong CDMO growth potential and a 34% upside. Know more about it.

Jefferies analyst Blayne Curtis reiterated a Buy rating on Astera Labs, Inc. (ALAB – Research Report) yesterday. The company’s shares closed ...

Jefferies Financial Group Inc. Chief Executive Officer Rich Handler assured junior bankers in a weekend memo that bosses will ...

In a report released today, Wei Sim from Jefferies maintained a Buy rating on Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX – Research ...

President Donald Trump announced 25% tariffs on all goods imported from Canada and Mexico and a 10% levy on China on Saturday ...

Analyst John Aiken says the consequences of the tariffs were “not effectively priced into equities,” with the S&P TSX Index ...

These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...